Comparing Usability of NEXThaler® with Other Inhaled Corticosteroid/Long-Acting β2-Agonist Fixed Combination Dry Powder Inhalers in Asthma Patients
Author:
Affiliation:
1. Krankenhaus Bethanien Moers, Moers, Germany.
2. Chiesi Farmaceutici S.p.A., Parma, Italy.
3. Lloyd's Register Consulting, London, UK.
4. Azienda Ospedaliera Universitaria Senese, Siena, Italy.
Publisher
Mary Ann Liebert Inc
Subject
Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine
Link
http://www.liebertpub.com/doi/pdf/10.1089/jamp.2013.1086
Reference39 articles.
1. Poor Adherence to Anti-inflammatory Medication in Asthma
2. The Brussels Declaration: the need for change in asthma management
3. Associations of patient outcomes with level of asthma control
4. Improvement of asthma control with a breath-actuated pressurised metred dose inhaler (BAI): a prescribing claims study of 5556 patients using a traditional pressurised metred dose inhaler (MDI) or a breath-actuated device
5. The DiskusTM: a review of its position among dry powder inhaler devices
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. BDP/FF NEXThaler to Improve Asthma Control Status in the Real World: The NEWTON Study;Journal of Asthma and Allergy;2023-10
2. The impact of possible improper use on the performance in vitro of NEXThaler in comparison with Ellipta inhaler;European Journal of Pharmaceutical Sciences;2023-04
3. Combined analysis of five non-interventional studies of the effectiveness, tolerability, and safety of the extrafine fixed dose beclomethasone/formoterol combination in the treatment of asthma in Austria;Respiratory Medicine;2023-02
4. Feedback systems in multi-dose dry powder inhalers;Advances in Dermatology and Allergology;2023
5. Assessment of extrafine beclomethasone/formoterol for the treatment of chronic obstructive pulmonary disease: A non-interventional study in a Bulgarian population;Pulmonary Pharmacology & Therapeutics;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3